Financial Statements and Exhibits . for Medtox

Send us Feedback

Medtox Scientific (MTOX)

	SUMMARY

	BULLS

	BEARS

	TOPICS

	DATA CENTRAL

	STOCK CHART

	SEC FILINGS

	BALANCE

	INCOME

	CASH FLOW

MTOX » Topics » Financial Statements and Exhibits .

This excerpt taken from the MTOX 8-K filed Nov 5, 2009.

Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is furnished as part of this report:


Exhibit No.		Description
99.1 99.2		MEDTOX Scientific, Inc. Corporate Fact Sheet dated October 29, 2009. Article published by Minneapolis/St. Paul Business Journal on October 30, 2009.

This excerpt taken from the MTOX 8-K filed Oct 20, 2009.

Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:


Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. conference call script dated October 14, 2009.

This excerpt taken from the MTOX 8-K filed Oct 16, 2009.

Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. Press Release, dated October 14, 2009.

This excerpt taken from the MTOX 8-K filed Jul 29, 2009.

Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.

Description

99.1

MEDTOX Scientific, Inc. Press Release, dated July 29, 2009.

This excerpt taken from the MTOX 8-K filed Jul 20, 2009.

Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:


Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. conference call script dated July 15, 2009.

This excerpt taken from the MTOX 8-K filed Jul 15, 2009.

Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. Press Release, dated July 15, 2009.

This excerpt taken from the MTOX 8-K filed Apr 21, 2009.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:


Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. conference call script dated April 15, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: April 21, 2009

By:

/s/ Richard J. Braun

Name: Richard J. Braun

Title:

Chief Executive Officer

INDEX TO EXHIBITS


Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. conference call script dated April 15, 2009.

This excerpt taken from the MTOX 8-K filed Apr 15, 2009.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. Press Release, dated April 15, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: April 15, 2009

By:

/s/ Richard J. Braun

Name: Richard J. Braun

Title:

Chief Executive Officer

INDEX TO EXHIBITS

Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. Press Release, dated April 15, 2009.

This excerpt taken from the MTOX 8-K filed Feb 20, 2009.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.

Description

99.1

MEDTOX Scientific, Inc. Press Release, dated February 19, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: February 20, 2009

By:

/s/ Richard J. Braun

Name: Richard J. Braun

Title:

Chief Executive Officer

INDEX TO EXHIBITS

Exhibit No.

Description

99.1

MEDTOX Scientific, Inc. Press Release, dated February 19, 2009.

This excerpt taken from the MTOX 8-K filed Feb 18, 2009.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:


Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. conference call script dated February 11, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: February 18, 2009

By:

/s/ Richard J. Braun

Name: Richard J. Braun

Title:

Chief Executive Officer

INDEX TO EXHIBITS


Exhibit No.		Description
99.1		MEDTOX Scientific, Inc. conference call script dated February 11, 2009.

This excerpt taken from the MTOX 8-K filed Feb 17, 2009.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibit is filed as part of this report:

Exhibit No.

Description

99.1

MEDTOX Scientific, Inc. Press Release, dated February 11, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: February 17, 2009

By:

/s/ Richard J. Braun

Name: Richard J. Braun

Title:

Chief Executive Officer

INDEX TO EXHIBITS

Exhibit No.

Description

99.1

MEDTOX Scientific, Inc. Press Release, dated February 11, 2009.

This excerpt taken from the MTOX 8-K filed Dec 23, 2008.

Item 9.01. Financial Statements and Exhibits.

(c)	Exhibits.

The following exhibits are filed as part of this report:


Exhibit No.		Description
10.1		Amendment to Employment Agreement, effective January 1, 2009, between the Company and Richard J. Braun.
10.2		Amendment to Employment Agreement, effective January 1, 2009, between the Company and James A. Schoonover.
10.3		Amendment to Employment Agreement, effective January 1, 2009, between the Company and Kevin J. Wiersma.
10.4		Amendment to Employment Agreement, effective January 1, 2009, between the Company and Susan E. Puskas.
10.5		Amendment to Employment Agreement, effective January 1, 2009, between the Company and B. Mitchell Owens.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MEDTOX Scientific, Inc.

Date: December 22, 2008

By:

/s/ Richard J. Braun

Name: Richard J. Braun

Title:

Chief Executive Officer

INDEX TO EXHIBITS


Exhibit No.		Description
10.1		Amendment to Employment Agreement, effective January 1, 2009, between the Company and Richard J. Braun.
10.2		Amendment to Employment Agreement, effective January 1, 2009, between the Company and James A. Schoonover.
10.3		Amendment to Employment Agreement, effective January 1, 2009, between the Company and Kevin J. Wiersma.
10.4		Amendment to Employment Agreement, effective January 1, 2009, between the Company and Susan E. Puskas.
10.5		Amendment to Employment Agreement, effective January 1, 2009, between the Company and B. Mitchell Owens.

"Financial Statements and Exhibits ." elsewhere:

Alliance HealthCare Services, Inc (AIQ)
AMAG Pharmaceuticals (AMAG)
Array BioPharma (ARRY)
Bio-Reference Laboratories (BRLI)
Candela (CLZR)
Conceptus (CPTS)
CryoLife (CRY)
DepoMed (DEPO)
DexCom (DXCM)
Enzo Biochem (ENZ)
EResearch Technology (ERES)
Home Diagnostics (HDIX)
Hooper Holmes (HH)
Endo Pharmaceuticals Solutions Inc. (IDEV)
Isis Pharmaceuticals (ISIS)
Inspire Pharmaceuticals (ISPH)
Arcadia Resources (KAD)
Lakeland Industries (LAKE)
Lannett Co (LCI)
LABORATORY CORP OF AMERICA HOLDINGS (LH)
National Dentex (NADX)
NightHawk Radiology Holdings (NHWK)
Nektar Therapeutics (NKTR)
NPS Pharmaceuticals (NPSP)
Obagi Medical Products (OMPI)
Optimer Pharmaceuticals (OPTR)
Oscient Pharmaceuticals (OSCI)
Osteotech (OSTE)
OraSure Technologies (OSUR)
Psychemedics (PMD)
Pharmaceutical Product Development (PPDI)
RadNet (RDNT)
OTIX GLOBAL, INC. (SNCI)
Sequenom (SQNM)
SunLink Health Systems (SSY)
Vascular Solutions (VASC)
Orthovita (VITA)
VNUS Medical Technologies (VNUS)
Young Innovations (YDNT)
Quest Diagnostics (DGX)

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.

Mobile | Advertise | Licensing & Partnerships | Blogger Tools | Jobs

Medtox Scientific (MTOX)

MTOX » Topics » Financial Statements and Exhibits .

EXCERPTS ON THIS PAGE:

RELATED TOPICS for MTOX:

"Financial Statements and Exhibits ." elsewhere: